In this free webinar, attendees will learn how to navigate the complex considerations of psychedelic clinical trials from a featured panel of psychedelic operational experts. Attendees will takeaway considerations for site selection, weighing their psychedelic experience, infrastructure and key team members. The panelists will also discuss how to identify appropriate participants for clinical research with psychedelics and how to avoid bias by management of blinding, controlling the placebo-response within efficacy assessments and training programs for raters and therapists. They will also cover how to navigate the existing regulatory frameworks and obtain the necessary licenses.
TORONTO, Ontario, Sept. 7, 2022 /PRNewswire-PRWeb/ -- Building on the initial research projects of the 1950s, the resurgent interest in psychedelic agents has transitioned from academic or government-sponsored projects into industry-sponsored drug development.
The potential benefit of psychedelics in the treatment of persistent psychiatric illnesses like depression and behavioral disorders has long been overshadowed by the notoriety of this class of agents being scheduled. The resurgence in this field poses a new challenge: conducting high-science, high-quality clinical trials with previously researched molecules within today's regulatory environment.
For sponsors, investigators and regulators, psychedelics pose new clinical trial considerations. Dosing patients with these investigational products requires careful selection of both the clinical site, supportive therapists, efficacy raters and the patient themselves. Trust and support are paramount in this unique research partnership.
Join panelists from Worldwide Clinical Trial's psychedelic operational teams as they discuss the unique requirements of psychedelic clinical development, demystifying the complex operations.
Join experts from Worldwide Clinical Trials, Richard Bennett (webinar moderator), Senior Director, Therapeutic Strategy Lead, Neuroscience; Julia Forte, Senior Director, Project Management; Christine K. Moore, PhD, Vice President, Neuroscience, Scientific Solutions; and Rolana Avrumson, MS, Vice President of Clinical Projects, Clinical Assessment Technologies, for the live webinar on Tuesday, September 27, 2022, at 10am EDT (3pm BST/UK).
For more information, or to register for this event, visit Psychedelic Research: Demystifying Complex Operations.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]
SOURCE Xtalks
Share this article